NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 22 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -46.7% | 17,155 | 0.0% | 0.00% | – |
| Q1 2022 | $15,000 | -50.0% | 17,155 | -29.8% | 0.00% | – |
| Q4 2021 | $30,000 | -67.4% | 24,422 | -0.9% | 0.00% | – |
| Q3 2021 | $92,000 | +12.2% | 24,642 | +0.3% | 0.00% | – |
| Q2 2021 | $82,000 | -76.4% | 24,579 | -68.9% | 0.00% | – |
| Q1 2021 | $348,000 | -18.1% | 78,993 | -2.3% | 0.00% | – |
| Q4 2020 | $425,000 | -11.3% | 80,860 | -5.4% | 0.00% | – |
| Q3 2020 | $479,000 | -23.8% | 85,444 | +9.3% | 0.00% | – |
| Q2 2020 | $629,000 | – | 78,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hayden Royal, LLC | 20,642 | $91,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 173,202 | $762,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $220,000 | 0.01% |
| Ameritas Investment Partners, Inc. | 378 | $2,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 9,817 | $43,000 | 0.00% |
| UBS Group AG | 2,841 | $13,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 3,926 | $17,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11,642 | $51,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 13,762 | $61,000 | 0.00% |
| NORTHERN TRUST CORP | 78,993 | $348,000 | 0.00% |